Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2007

Aug 10, 2007

34117_dirs_2007-08-10_cfab4d3b-aec6-456c-9743-c72caed24bf3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2007-08-08

Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-08-08 Common Stock M 1000000 $0.25 Acquired 2521130 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-08-08 Employee Stock Option $0.25 M 1000000 Disposed 2013-05-05 Common Stock (1000000) Direct

Footnotes

F1: Amount of securities beneficially owned represents shares held by Mr. Krusos and excludes shares Mr. Krusos has the right to
acquire upon exercise of stock options pursuant to CopyTele, Inc. stock incentive plans

F2: Right-To-Buy, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.